Trial intelligence / Profile preview

SPF and UVA Protection Assay of BAY987521

NCT02774252Completed

Sponsor
Bayer
Start
Aug 2015
Primary completion
Sep 2015
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of BAY987521 in sunburn, sponsored by Bayer. Primary endpoints: Minimal Erythema Dose at 15 minutes and Minimal Persistent Pigment Darkening Dose at 15 minutes. Started Aug 2015; status: completed.

02

Drugs

BAY987521
03

Conditions

sunburn

Beyond the preview

Go deeper on NCT02774252.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02774252.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call